期刊文献+

类风湿关节炎患者外周血淋巴细胞趋化因子受体CCR7的表达及其临床意义 被引量:8

The Clinical Significance of CCR7 Expression on Lymphocyte in the Patients with Rheumatoid Arthritis
下载PDF
导出
摘要 目的探讨CC族趋化因子受体CCR7在类风湿关节炎(RA)发病机制中的作用及其临床意义。方法选取30例RA患者(RA组)和20例健康体检者(正常对照组)。应用流式细胞检测术检测两组受检者外周血淋巴细胞表面CCR7的表达,并根据患者的触痛关节数、肿胀关节数、红细胞沉降率计算出患者的疾病活动性积分(DAS28),分析CCR7的表达与疾病活动性的关系。结果 RA组患者外周血CD4+T细胞和CD8+T细胞上CCR7的表达率〔(74.5±13.7)%与(57.9±11.8)%〕均显著高于正常对照组〔(16.7±2.0)%与(16.6±1.6)%〕,差异有统计学意义(P<0.01);且RA组患者外周血CD4+T细胞上CCR7的表达率显著高于CD8+T细胞,差异有统计学意义(P<0.05)。RA组患者外周血CD4+T细胞CCR7的表达与DAS28呈正相关(r=0.836,P<0.01)。结论 CCR7在RA患者外周血淋巴细胞上的表达异常增加,尤其是在CD4+T细胞上;CCR7在CD4+T细胞上的异常表达可能是导致RA病情活动的重要因素之一。 Objective To explore the role and the clinical significance of CCR7 in the pathogenesis of rheumatoid arthritis(RA).Methods 30 patients with RA(RA group)and 20 healthy persons(normal control group) were selected.The expressions of CCR7 on the peripheral blood lymphocytes in the two groups were detected by flow cytometry(FCM).Moreover,we calculated disease activity score(DAS28) of every patient with RA and analyzed the relativity of CCR7 expression and the disease activity.Results The levels of CCR7 in CD+4T and CD+8 T cells from RA group〔(74.5±13.7)% and(57.9±11.8)%〕were higher than that from normal controls〔(16.7±2.0)% and(16.6±1.6)%〕.The difference was significant(P0.01).The level of CCR7 in CD+4T cells from RA group was higher than that in CD+8T cells,the difference was significant(P0.05).The level of CCR7 in CD+4 T cell was positively related to DAS28(r=0.836,P0.01).Conclusion The abnormal expression of CCR7 is increased on peripheral blood lymphocytes from RA patients,especially on CD+4 T cells.The abnormal expression of CCR7 on CD+4T cells is probably one of the key factors resulting in the disease development of RA.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第30期3358-3360,共3页 Chinese General Practice
关键词 关节炎 类风湿 T淋巴细胞 受体 CCR7 疾病活动性积分 Arthritis rheumatoid T-lymphocyte Receptors CCR7 Disease activity score
  • 相关文献

参考文献11

  • 1Szekanecz Z,Szücs G,Szántó S,et al.Chemokines in rheumatic diseases[J].Curr Drug Targets,2006,7(1):91-102.
  • 2Yoshida R,Nagira M,Kitaura M,et al.Secondary lymphoid-tissue chemokine is a function ligand for the CC chemokine receptor CCR7[J].J Biol Chem,1998,273(12):7118-7122.
  • 3Frster R,Davalos-Misslitz AC,Rot A.CCR7 and its ligands:balancing immunity and tolerance[J].Nat Rev Immunol,2008,8(5):362-371.
  • 4Kim CH,Pelus LM,Appelbaum EK,et al.CCR7 ligands SLC/6Ckine/Exodus-2/TCA-4 and CKb-11/MIP-3b/ELC are chemoattractants for CD56(+) CD16(-) NK cells and late stage lymphoid progenitors[J].Cell Immunol,1999,193(2):226-235.
  • 5Robertsion MJ,Williams BT,Christopherson K,et al.Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokine[J].Cell Immunol,2000,199(1):208-214.
  • 6Noelia Snchez-Snchez,Lorena Riol-Blanco,Gonzalo de la Rosa,et al.Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells[J].Blood,2004,104(3):619-625.
  • 7曾惠琼,张丹霞,余贺杲,董慧娟,张新生.早期类风湿关节炎中三种自身免疫性抗体联合检测的临床价值[J].中国全科医学,2008,11(8):650-651. 被引量:8
  • 8Page G,Miossec P.Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression[J].J Pathol,2004,204(1):28-38.
  • 9Weninger W,Carlsen HS,Goodarzi M,et al.Nave T cell recruitment to nonlymphoid tissues:a role for endothelium expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis[J].J Immunol,2003,170(9):4638-4648.
  • 10Rangel-Moreno J,Hartson L,Navarro C.Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis[J].J Clin Invest,2006,116(12):3183-3194.

二级参考文献8

共引文献7

同被引文献34

引证文献8

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部